Intelligent Bio Solutions Inc. is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Intelligent Bio Solutions Inc., formerly known as GBS Inc., is based in NEW YORK.
| Revenue (Most Recent Fiscal Year) | $3.11M |
| Net Income (Most Recent Fiscal Year) | $-10.16M |
| PE Ratio (Current Year Earnings Estimate) | -- |
| PE Ratio (Trailing 12 Months) | -- |
| PEG Ratio (Long Term Growth Estimate) | -- |
| Price to Sales Ratio (Trailing 12 Months) | 3.21 |
| Price to Book Ratio (Most Recent Quarterly Book Value per Share) | 2.05 |
| Price to Cash Ratio (Most Recent Annual Cash Flow per Share) | -- |
| Pre-Tax Margin (Trailing 12 Months) | -320.94% |
| Net Margin (Trailing 12 Months) | -319.85% |
| Return on Equity (Trailing 12 Months) | -176.55% |
| Return on Assets (Trailing 12 Months) | -93.89% |
| Current Ratio (Most Recent Fiscal Quarter) | 1.12 |
| Quick Ratio (Most Recent Fiscal Quarter) | 0.97 |
| Debt to Common Equity (Most Recent Fiscal Quarter) | 0.00 |
| Inventory Turnover (Trailing 12 Months) | 1.67 |
| Book Value per Share (Most Recent Fiscal Quarter) | $0.72 |
| Earnings per Share (Most Recent Fiscal Quarter) | $-0.44 |
| Earnings per Share (Most Recent Fiscal Year) | $-6.38 |
| Diluted Earnings per Share (Trailing 12 Months) | -- |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Medical Devices |
| Common Shares Outstanding | 6.91M |
| Free Float | 6.80M |
| Market Capitalization | $10.30M |
| Average Volume (Last 20 Days) | 0.12M |
| Beta (Past 60 Months) | 4.63 |
| Percentage Held By Insiders (Latest Annual Proxy Report) | 1.54% |
| Percentage Held By Institutions (Latest 13F Reports) | 32.97% |
| Annual Dividend (Based on Last Quarter) | $0.00 |
| Dividend Yield (Based on Last Quarter) | 0.00% |